Effectiveness of single-dose azithromycin to treat latent yaws: a longitudinal comparative cohort study

Authors :: Oriol Mitjà, DrMD
Camila González-Beiras, BSc
Charmie Godornes, BSc
Reman Kolmau, BSc
Wendy Houinei, HEO
Haina Abel, BSc
August Kapa, BSc
Raymond Paru, BSc
Sibauk V Bieb, MaHM
James Wangi, MPH
Sergi Sanz, MSc
Kingsley Asiedu, MPH
Sheila A Lukehart, ProfPhD
Quique Bassat, ProfMD
Source :: The Lancet Global Health, Vol 5, Iss 12, Pp e1268-e1274 (2017)
Publication Year :: 2017
Publisher :: Elsevier, 2017.
Abstract: Summary: Background: Treatment of latent yaws is a crucial component of the WHO yaws eradication strategy to prevent relapse and the resulting transmission to uninfected children. We assessed the effectiveness of single-dose azithromycin to treat patients with latent yaws. Methods: This population-based cohort study included children (age

Full Text Access

Tools